JANEJIRA CHAIYASIT: Open Payments
NPI 1588080139 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$146 in 6 payments from 4 companies in 2025. Trend: 2023 $47 · 2024 $33 · 2025 $146
Food & beverage: $146
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $61 |
| Lilly USA, LLC | 2 | $39 |
| Amgen Inc. | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
Products named: Ozempic, MOUNJARO, REPATHA, JARDIANCE.
Industry payments across NY — which companies pay providers there.
